Colin Castleberry

Colin Castleberry, Ph.D., is a Senior Scientist at Amgen since August 2022, previously serving as a Biotechnology Researcher at AbbVie from June 2020 to August 2022, where Colin conducted bioinformatics and quantitative systems pharmacology research to enhance drug development. Colin also worked as a Research Consultant for the Amos Engineering Education Laboratory at the University of Illinois at Urbana-Champaign, providing data analysis and academic writing support from January to June 2022. Earlier, Colin gained experience as a Graduate Research Assistant and Graduate Teaching Assistant at the University of Illinois Urbana-Champaign, where Colin taught various bioengineering courses and received the Teaching Excellence Fellowship in 2020. Colin earned a Ph.D. in Bioengineering and Biomedical Engineering in May 2022 and a Bachelor of Science in the same field in May 2014 from the University of Illinois Urbana-Champaign.